NASA Forms Group to Develop VTE Risk Score for Astronauts
In April 2026, NASA's Office of the Chief Health and Medical Officer (OCHMO) established a working group to address the risk of venous thromboembolism (VTE) in astronauts. This initiative stems from updated VTE case information and new data indicating altered blood flow patterns within a group of astronauts. The working group will review these findings and discuss ongoing research and clinical efforts aimed at reducing VTE risk during space missions. The ultimate goal is to create a VTE risk score algorithm specifically tailored for astronauts. This proactive approach seeks to enhance crew health and safety during long-duration spaceflights, acknowledging the unique physiological challenges of the space environment. Further details on the research and clinical activities are expected as the group progresses.
The formation of this working group by NASA's OCHMO highlights a critical need to proactively manage astronaut health risks, particularly VTE, which may be exacerbated by the physiological stresses of spaceflight. Developing a specific risk score algorithm acknowledges that standard terrestrial VTE risk factors may not fully capture the unique conditions of microgravity and prolonged isolation. This initiative aligns with the broader trend of leveraging data analytics and predictive modeling for personalized health management, a necessity for increasingly ambitious space exploration missions. The focus on mitigating risk through research and clinical activities suggests a systems-level approach to astronaut well-being, aiming to ensure mission success and crew safety by addressing potential health vulnerabilities before they become critical.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.